Daniel Böhringer
Daniel Böhringer
University Eye Hospital Freiburg
Verified email at - Homepage
Cited by
Cited by
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis
A Petzold, LJ Balcer, PA Calabresi, F Costello, TC Frohman, EM Frohman, ...
The Lancet Neurology 16 (10), 797-812, 2017
Trends in corneal transplantation from 2001 to 2016 in Germany: a report of the DOG–section cornea and its keratoplasty registry
E Flockerzi, P Maier, D Böhringer, H Reinshagen, F Kruse, C Cursiefen, ...
American journal of ophthalmology 188, 91-98, 2018
Trabectome surgery for primary and secondary open angle glaucomas
JF Jordan, T Wecker, C van Oterendorp, A Anton, T Reinhard, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 251 (12), 2753-2760, 2013
Corneal surface reconstruction using adult mesenchymal stem cells in experimental limbal stem cell deficiency in rabbits
H Reinshagen, C Auw‐Haedrich, RV Sorg, D Boehringer, P Eberwein, ...
Acta ophthalmologica 89 (8), 741-748, 2011
Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV
T Wecker, C Ehlken, A Bühler, C Lange, H Agostini, D Böhringer, A Stahl
British Journal of Ophthalmology 101 (3), 353-359, 2017
Influence of donor characteristics on descemet membrane endothelial keratoplasty
S Heinzelmann, S Hüther, D Böhringer, P Eberwein, T Reinhard, P Maier
Cornea 33 (6), 644-648, 2014
Long-term results of allogeneic penetrating limbo-keratoplasty in total limbal stem cell deficiency
T Reinhard, H Spelsberg, L Henke, T Kontopoulos, J Enczmann, ...
Ophthalmology 111 (4), 775-782, 2004
The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study
J Hillenkamp, T Reinhard, RS Ross, D Böhringer, O Cartsburg, ...
Ophthalmology 109 (5), 845-850, 2002
Outcomes of Descemet membrane endothelial keratoplasty, Descemet stripping automated endothelial keratoplasty and penetrating keratoplasty from a single centre study
S Heinzelmann, D Böhringer, P Eberwein, T Reinhard, P Maier
Graefe's Archive for Clinical and Experimental Ophthalmology 254 (3), 515-522, 2016
Influencing factors on chronic endothelial cell loss characterised in a homogeneous group of patients
D Böhringer, T Reinhard, H Spelsberg, R Sundmacher
British journal of ophthalmology 86 (1), 35-38, 2002
Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial
T Reinhard, A Reis, D Böhringer, M Malinowski, A Voiculescu, P Heering, ...
Graefe's archive for clinical and experimental ophthalmology 239 (5), 367-372, 2001
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study
J Hillenkamp, T Reinhard, RS Ross, D Böhringer, O Cartsburg, ...
Archives of Ophthalmology 119 (10), 1487-1491, 2001
Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients
C Ehlken, M Helms, D Böhringer, HT Agostini, A Stahl
Clinical ophthalmology (Auckland, NZ) 12, 13, 2018
Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study
F Birnbaum, D Böhringer, Y Sokolovska, R Sundmacher, T Reinhard
Transplantation 79 (8), 964-968, 2005
Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study
C Cursiefen, E Viaud, F Bock, B Geudelin, A Ferry, P Kadlecová, M Lévy, ...
Ophthalmology 121 (9), 1683-1692, 2014
Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD
C Ehlken, S Jungmann, D Böhringer, HT Agostini, B Junker, A Pielen
Eye 28 (5), 538-545, 2014
Clinical experience with eplerenone to treat chronic central serous chorioretinopathy
B Cakir, F Fischer, C Ehlken, A Bühler, A Stahl, G Schlunck, D Böhringer, ...
Graefe's Archive for Clinical and Experimental Ophthalmology 254 (11), 2151-2157, 2016
Clinical results of 123 femtosecond laser-assisted penetrating keratoplasties
F Birnbaum, A Wiggermann, PC Maier, D Böhringer, T Reinhard
Graefe's Archive for Clinical and Experimental Ophthalmology 251 (1), 95-103, 2013
Matching of the minor histocompatibility antigen HLA-A1/HY may improve prognosis in corneal transplantation
D Böhringer, E Spierings, J Enczmann, S Böhringer, R Sundmacher, ...
Transplantation 82 (8), 1037-1041, 2006
Improvement of graft prognosis in penetrating normal-risk keratoplasty by HLA class I and II matching
T Reinhard, D Böhringer, J Enczmann, G Kögler, S Mayweg, P Wernet, ...
Eye 18 (3), 269-277, 2004
The system can't perform the operation now. Try again later.
Articles 1–20